S. Louise Phanstiel - 31 Dec 2021 Form 5 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Director
Signature: By: Nathan A. Smith For: S. Louise Phanstiel
Issuer symbol: MYGN
Transactions as of: 31 Dec 2021
Net transactions value: $0
Form type: 5
Filing time: 26 Jan 2022, 15:37:45 UTC
Previous filing: 06 Aug 2021
Next filing: 03 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MYGN	Common Stock						33,119	31 Dec 2021	The Phanstiel Trust	F1
holding	MYGN	Common Stock						79,527	31 Dec 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person previously reported total beneficial ownership of 112,646 shares of common stock, consisting of 91,646 shares of common stock held directly and 21,000 shares of common stock held indirectly through The Phanstiel Trust. The Reporting Person's total beneficial ownership of common stock remains the same as previously reported, but this Form 5 is being filed to correct the number of shares of common stock held directly by the Reporting Person and held indirectly by the Reporting Person through The Phanstiel Trust.

Content

The Reporting Person previously reported total beneficial ownership of 112,646 shares of common stock, consisting of 91,646 shares of common stock held directly and 21,000 shares of common stock held indirectly through The Phanstiel Trust. The Reporting Person's total beneficial ownership of common stock remains the same as previously reported, but this Form 5 is being filed to correct the number of shares of common stock held directly by the Reporting Person and held indirectly by the Reporting Person through The Phanstiel Trust.